₹ 3,263.90
-38.50 (-1.17%)
G
Gland Pharma
₹ 3,263.90
Gland Pharma Share Price Today
Gland Pharma (GLAND) share price is trading at ₹3,263.90 on the NSE as of November 11, 2026 at 03:57 PM, down by 1.17% from its previous close of ₹3,302.40. In todays trading session GLAND reached a high of 3,370.50 and low of 3,233.10. The average traded price for today is 3,293.33. The 50 DMA stands at 2,987.00 and 200 DMA is at 2,325.33. Looking at intraday trend, the stock is in Downtrend.
Stock Overview
- Symbol : GLAND
- Open : ₹3,344.60
- Previous Close : ₹3,302.40
- Day's Range : ₹3,233.10 – ₹3,370.50
- 52-Week Range : ₹1,573.60 – ₹3,374.00
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
GLAND Stock Performance
Markets Today
High
3,370.50
Low
3,233.10
Open at
3,344.60
Prev Close
3,302.40
Volumes
5,49,530
Avg Price
3,293.33
Lower Circuit
2,611.20
Upper Circuit
3,916.60
Last Traded Details
Quantity
1
Time
15:57:55
Price Movement
Historical Performance
3 M High
3,374.00
3 M Low
2,610.10
1 Yr High
3,374.00
1 Yr Low
1,573.60
3 Yr High
3,374.00
3 Yr Low
1,277.80
5 Yr High
4,062.95
5 Yr Low
861.00
1-Year Performance
GLAND Pros and Cons
US revenue grew from ₹8,685 Cr in Q3 FY25 to ₹11,795 Cr in Q2 FY26, now contributing 64% of total sales
Total income increased from ₹13,720 Cr in Q4 FY25 to ₹19,026 Cr in Q2 FY26, reflecting strong top-line momentum
US ANDA filings surged from 8 in Q4 FY25 to 11 in Q2 FY26, signaling a robust future product pipeline
Inventory days reduced from 132 in Q3 FY25 to 96 in Q2 FY26, improving stock turnover efficiency
Net cash held steady at ₹32,216 Cr in Q2 FY26, up from ₹23,191 Cr in Q3 FY25, ensuring financial stability
EBITDA margin fell from 40% in Q4 FY25 to 26% in Q2 FY26, indicating significant profitability compression
PAT margin dropped from 33% in Q4 FY25 to 16% in Q2 FY26, reducing bottom-line efficiency
Receivable days worsened from 94 in Q1 FY26 to 123 in Q2 FY26, slowing down cash collection
Rest of the World revenue plummeted from ₹3,000 Cr in Q3 FY25 to ₹387 Cr in Q2 FY26, showing severe contraction
GLAND Analyst Rating
Buy
Analysts have suggested that investors can
Buy this Stock
- By Refinitiv from 15 analysts
Buy
66.67%
Hold
6.67%
Sell
26.67%
Get forecast for Price, ROA & ROE based on analyst ratings.
GLAND Share Price History
GLAND Fundamentals
Company Valuation
Market Cap (₹ Cr.)
53,858
PE Ratio
44.10
PB Ratio
5.10
Dividend Yield
0.61%
ROE
9.92%
ROCE
13.74%
Book Value (₹)
647.57
Face Value (₹)
1.00
Analyse GLAND with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 51.83% | 51.83% | 51.83% | 51.77% | 45.75% |
| Domestic Institutional Investors (DII) | 32.64% | 32.98% | 33.35% | 30.44% | 33.21% |
| Foreign Institutional Investors (FII) | 7.91% | 7.58% | 7.30% | 8.74% | 10.36% |
| Public Investors | 2.57% | 2.57% | 2.53% | 3.50% | 4.63% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Gland Pharma Return Calculator
Note: Past profits do not guarantee future returns.
GLAND Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
GLAND Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for GLAND
Margin on GLAND
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
GLAND Financials Summary
In Crores
GLAND Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check GLAND latest Company Filings, Investor Presentation & Conference Call details.
GLAND Revenue Growth
All values are in Crores
Revenue
Profit
Loss
GLAND Similar Stocks
FAQs on GLAND
What is the share price of Gland Pharma?
What is the 52W high and 52W low of Gland Pharma?
What is the return on Gland Pharma share?
- Past 1 year: 75.20%
- Past 3 years: 102.39%
- Past 5 years: -9.94%
What is the PE and PB Ratio of Gland Pharma?
What is the EPS of Gland Pharma?
What is the shareholding pattern of Gland Pharma?
- DIIs - 33.21%
- FII - 10.36%
- Promoters - 45.75%
- Public Investors 4.63%
- Goverenment - 0.01%
How to buy Gland Pharma shares online?
How to buy Gland Pharma shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Gland Pharma share
- Tap on “Buy”
